Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Reexamination Certificate
2005-03-11
2008-03-11
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
C424S009300, C424S009360, C424S009361, C424S009362
Reexamination Certificate
active
07341711
ABSTRACT:
A new use in magnetic resonance imaging employing a field greater than 1.5 Tesla, of a porphyrin compound of the following general formula I is provided:in which R0and R′0are such that the compound is soluble in a biological medium, and M denotes a paramagnetic metal ion, advantageously Mn3+. The present invention also relates to novel porphyrin compounds.
REFERENCES:
patent: 4647447 (1987-03-01), Gries et al.
patent: 4804529 (1989-02-01), Bardy et al.
patent: 4986256 (1991-01-01), Cohen et al.
patent: 5169944 (1992-12-01), Nelson et al.
patent: 5236915 (1993-08-01), Fiel
patent: 5262532 (1993-11-01), Tweedle et al.
patent: 5284647 (1994-02-01), Niedballa et al.
patent: 5674467 (1997-10-01), Maier et al.
patent: 5695739 (1997-12-01), Schmitt-Willich et al.
patent: 5712389 (1998-01-01), Meyer et al.
patent: 5980864 (1999-11-01), Platzek et al.
patent: 6123920 (2000-09-01), Gunther et al.
patent: 6187285 (2001-02-01), Meyer et al.
patent: 6251367 (2001-06-01), Platzek et al.
patent: 6440956 (2002-08-01), Port
patent: 6537520 (2003-03-01), Rajopadhye et al.
patent: 2002/0128472 (2002-09-01), Platzek et al.
patent: 2003/0100752 (2003-05-01), Robinson
patent: 0 071 564 (1983-02-01), None
patent: 0 133 603 (1985-02-01), None
patent: 0 203 962 (1986-12-01), None
patent: 0 230 893 (1987-08-01), None
patent: 0 290 047 (1988-11-01), None
patent: 0 292 689 (1988-11-01), None
patent: 0 336 879 (1989-10-01), None
patent: 0 350 948 (1990-01-01), None
patent: 0 405 704 (1991-01-01), None
patent: 0 425 571 (1991-05-01), None
patent: 0 448 191 (1991-09-01), None
patent: 0 661 279 (1995-07-01), None
patent: 0 922 700 (1999-06-01), None
patent: 1 148 057 (2001-10-01), None
patent: 1 183 255 (2002-03-01), None
patent: 11-217385 (1999-10-01), None
patent: WO-86/02841 (1986-05-01), None
patent: WO-90/01024 (1990-02-01), None
patent: WO-94/19352 (1994-09-01), None
patent: WO-95/17910 (1995-04-01), None
patent: WO-95/31219 (1995-11-01), None
patent: WO-02/48119 (2002-06-01), None
patent: WO-03/074523 (2003-09-01), None
R.J. Fiel et al.,Magnetic Resonance Imaging, vol. 8, (1990), pp. 255-259. XP000983410.
Rashid Fawwaz et al.,Nucl. Med. Biol., vol. 17, No. 10, (1990), pp. 65-72, XP008023293.
Akira Matsumura et al.,Neurol. Med. Chir., vol. 37, (1997), pp. 327-331. XP001084819.
Takehara Yasuo et al.,Magnetic Resonance in Medicine, vol. 47, No. 3, (2002), pp. 549-553. XP002291536.
Schmiedl Up et al.,Investigative Radiology, vol. 27, No. 7, (1992), pp. 536-542. XP002291537.
David A. Place et al.,Magnetic Resonance Imaging, vol. 10, No. 6, (1992), pp. 919-928. XP002291538.
S.W. Kim et al.,Nippon Acta Radiologica, vol. 50, No. 2, (1990), pp. 192-194. XP002291539.
J. Maurer et al.,Der Radiologe, vol. 39, No. 5, (May 1999), pp. 422-427. XP002291540.
L.J. Wilmes et al.,Journal of Magnetic Resonance Imaging, vol. 3, No. 1, (Jan. 1993), pp. 5-12. XP002291541.
G. Marchal et al.,European Radiology, Springer International, Berlin, vol. 6, No. 1, (1996), pp. 2-8. XP009025342.
Polivina Jolicia F. Gauuan et al.,Bioorganic&Medical Chemistry, vol. 10, (2002), pp. 3013-3021. XP002292093.
Birch & Stewart Kolasch & Birch, LLP
Guerbet
Jones Dameron L.
LandOfFree
Porphyrin compounds and their use in high-field MRI does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Porphyrin compounds and their use in high-field MRI, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Porphyrin compounds and their use in high-field MRI will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3966262